Search alternatives:
significant substantial » significant potential (Expand Search), significant spatial (Expand Search)
significant agreement » significant improvement (Expand Search), significant advancement (Expand Search), significant enrichment (Expand Search)
substantial decrease » substantial increase (Expand Search), substantially increased (Expand Search)
agreement decrease » greatest decrease (Expand Search)
Showing 81 - 100 results of 4,025 for search '(( significant agreement decrease ) OR ( significant substantial decrease ))', query time: 0.32s Refine Results
  1. 81
    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 82
    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 83
    Average purchase costs of 3GCs and all oral antimicrobials per 100 patient-days from Phases 1–4.

    Average purchase costs of 3GCs and all oral antimicrobials per 100 patient-days from Phases 1–4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 84
    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 85
    S1 Dataset -

    S1 Dataset - by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 86
    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  7. 87
    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  8. 88
    Pop-up for oral 3GC prescription.

    Pop-up for oral 3GC prescription. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  9. 89
    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  10. 90
    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  11. 91
    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 92
    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  13. 93
    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 94
    Patients’ histories are presented in decreasing length of observation and colour coded as red for the days of use or referred use and green for abstinence days.

    Patients’ histories are presented in decreasing length of observation and colour coded as red for the days of use or referred use and green for abstinence days. by Francesco Lolli (2530471)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  15. 95
    Negativity ratings (mean ± SE) during <i>attend/negative</i> trials (left) and <i>decrease/negative</i> trials (right) of the emotion regulation task, in the TSD (red) and WR (blue) conditions.

    Negativity ratings (mean ± SE) during <i>attend/negative</i> trials (left) and <i>decrease/negative</i> trials (right) of the emotion regulation task, in the TSD (red) and WR (blue... by Anthony R. Stenson (11378981)

    Published 2021
    Save to List
    Saved in:
  16. 96
    Comparison of agreement in the order based on the SD-TOPSIS technique across groups of combinations - B1-B5 vs. C1-C10 vs. D1-D10.

    Comparison of agreement in the order based on the SD-TOPSIS technique across groups of combinations - B1-B5 vs. C1-C10 vs. D1-D10. by Roman Vavrek (13200141)

    Published 2024
    Save to List
    Saved in:
  17. 97
    Baseline characteristics of women by randomization method<sup>$</sup> (mITT analysis).

    Baseline characteristics of women by randomization method<sup>$</sup> (mITT analysis). by Chanel Avenant (409756)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 98
    Trial profile.

    Trial profile. by Chanel Avenant (409756)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 99
    Mean percentage changes (95% CI) in total testosterone, SHBG and free testosterone (mITT analysis).

    Mean percentage changes (95% CI) in total testosterone, SHBG and free testosterone (mITT analysis). by Chanel Avenant (409756)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 100
    Pairwise comparisons of hormonal results for DMPA-IM vs NET-EN expressed as mean percentage differences (95% CI) (mITT analysis).

    Pairwise comparisons of hormonal results for DMPA-IM vs NET-EN expressed as mean percentage differences (95% CI) (mITT analysis). by Chanel Avenant (409756)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: